Related references
Note: Only part of the references are listed.Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species
Xiao-Bing Zhang et al.
STEM CELLS (2007)
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo
Kerstin Schwarzwaelder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy
Annette Deichmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy
Alessandro Aiuti et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells
Brian C. Beard et al.
MOLECULAR THERAPY (2007)
Gene therapy for severe combined immunodeficiency: are we there yet?
Marina Cavazzana-Calvo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus
Brian C. Beard et al.
HUMAN GENE THERAPY (2007)
Retroviral vector insertion sites associated with dominant hematopoietic clones mark stemness pathways
Olga S. Kustikova et al.
BLOOD (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Human cancers express a mutator phenotype
Jason H. Bielas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
H. Bobby Gaspar et al.
MOLECULAR THERAPY (2006)
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy
Yan Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque
Ruth Seggewiss et al.
BLOOD (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells
S Pilat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Leukemias following retroviral transfer of multildrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis
U Modlich et al.
BLOOD (2005)
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking
O Kustikova et al.
SCIENCE (2005)
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy
T Neff et al.
BLOOD (2005)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation
B Schiedlmeier et al.
BLOOD (2003)
Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model
T Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein
J Krosl et al.
NATURE MEDICINE (2003)
A novel EVIl gene family, MEL1 lacking a PR domain (MELlS) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation
I Nishikata et al.
BLOOD (2003)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
HOXB4-induced expansion of adult hematopoietic stem cells ex vivo
J Antonchuk et al.
CELL (2002)
HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation
J Antonchuk et al.
EXPERIMENTAL HEMATOLOGY (2001)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)